Point72 Middle East FZE »

Adaptive Biotechnologies Cor shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $416k 85k 4.90
2022-12-31 $26k 3.5k 7.64

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
Vanguard Group
ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Point72 Asset Management
Massachusetts Financial Services
Dimensional Fund Advisors
Blue Water Life Science Advisors
Braidwell
Gilder, Gagnon, Howe & Co
Eagle Health Investments
Federated Investors
Standard Life Aberdeen
Nordea Investment Management Ab

View all funds holding Adaptive Biotechnologies Cor